
9 Meters Biopharma NMTR
Quarterly report 2023-Q1
added 05-15-2023
9 Meters Biopharma Depreciation & Amortization 2011-2025 | NMTR
Annual Depreciation & Amortization 9 Meters Biopharma
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.52 K | 7.57 K | 18.5 K | 21.6 K | 19.6 K | 5.79 K | 131 K | 54 K | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 131 K | 5.79 K | 33.3 K |
Quarterly Depreciation & Amortization 9 Meters Biopharma
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.33 K | - | 5.98 K | 4.41 K | 1.63 K | - | 4.66 K | 3.33 K | 1.11 K | - | 16.9 K | 9.74 K | 5.28 K | - | 16.1 K | 10.4 K | 5.14 K | - | 14.4 K | 9.28 K | 2.69 K | - | 2.52 K | 1.67 K | 1 K | - | 98 K | 65 K | 33 K | - | 21 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 98 K | 1 K | 14.5 K |
Depreciation & Amortization of other stocks in the Biotechnology industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Autolus Therapeutics plc
AUTL
|
7.55 M | $ 1.87 | 11.68 % | $ 477 M | ||
|
Aclaris Therapeutics
ACRS
|
807 K | $ 3.0 | -0.99 % | $ 232 M | ||
|
Alpine Immune Sciences
ALPN
|
597 K | - | - | $ 2.17 B | ||
|
Aptorum Group Limited
APM
|
1.13 M | $ 1.1 | -3.51 % | $ 6 M | ||
|
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | ||
|
AIkido Pharma
AIKI
|
105 K | - | 1.93 % | $ 17.4 M | ||
|
AlloVir
ALVR
|
398 K | - | 4.14 % | $ 49.1 M | ||
|
Ampio Pharmaceuticals
AMPE
|
122 K | - | -11.43 % | $ 502 K | ||
|
BioVie
BIVI
|
229 K | $ 1.22 | 0.83 % | $ 1.8 M | ||
|
Applied Molecular Transport
AMTI
|
3.13 M | - | - | $ 10.1 M | ||
|
AVROBIO
AVRO
|
617 K | - | 1083.1 % | $ 745 M | ||
|
BioDelivery Sciences International
BDSI
|
140 K | - | -4.8 % | $ 255 M | ||
|
Athersys
ATHX
|
1.43 M | - | 3.77 % | $ 22.4 M | ||
|
ARCA biopharma
ABIO
|
27 K | - | 1052.0 % | $ 415 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
11 K | - | -9.72 % | $ 5.89 M | ||
|
Acasti Pharma
ACST
|
7 K | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
9.45 M | - | -15.15 % | $ 60.3 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
14 K | $ 0.17 | -18.84 % | $ 370 M | ||
|
Berkeley Lights
BLI
|
9 M | - | -7.31 % | $ 87 M | ||
|
Albireo Pharma
ALBO
|
274 K | - | -0.23 % | $ 916 M | ||
|
Catalyst Biosciences
CBIO
|
1.07 M | $ 12.12 | -1.86 % | $ 798 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
28.2 M | $ 26.86 | -0.96 % | $ 1.3 B | ||
|
BeiGene, Ltd.
BGNE
|
172 M | - | 0.49 % | $ 251 B | ||
|
Calithera Biosciences
CALA
|
300 K | - | -10.95 % | $ 876 K | ||
|
Anika Therapeutics
ANIK
|
6.43 M | $ 9.53 | -0.21 % | $ 140 M | ||
|
Certara
CERT
|
1.99 M | $ 8.85 | -0.45 % | $ 1.42 B | ||
|
bluebird bio
BLUE
|
28 M | - | - | $ 546 M | ||
|
Arena Pharmaceuticals
ARNA
|
3.87 M | - | -6.81 % | $ 3.04 B | ||
|
Acer Therapeutics
ACER
|
66 K | - | 2.71 % | $ 14 M | ||
|
Axon Enterprise
AXON
|
48.4 M | $ 583.1 | -0.13 % | $ 44.2 B | ||
|
Ayala Pharmaceuticals
AYLA
|
162 K | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
5.38 M | $ 2.55 | 4.08 % | $ 16 M | ||
|
ChromaDex Corporation
CDXC
|
663 K | - | -0.88 % | $ 598 M | ||
|
Acorda Therapeutics
ACOR
|
31.7 M | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
41 K | - | -5.38 % | $ 6.06 M | ||
|
Celldex Therapeutics
CLDX
|
3.18 M | $ 25.93 | -1.8 % | $ 1.67 M | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
24.9 M | $ 11.43 | 2.65 % | $ 739 M |